ONO-6950 + Placebo + Montelukast
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedAbout ONO-6950 + Placebo + Montelukast
ONO-6950 + Placebo + Montelukast is a phase 2 stage product being developed by Ono Pharmaceutical for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT01551147. Target conditions include Asthma.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01551147 | Phase 2 | Completed |
Competing Products
20 competing products in Asthma